Tag: Precision drugs and DNA repair effective for cancer treatment

Precision drugs and DNA repair effective for cancer treatment

March 13, 2019

The advancements in immunotherapies boast some 10-20% of patients who are responsive to treatment, though many cancers still evade detection by the immune system. But, recent studies have suggested that treatment with PARP inhibitors in precision drugs cause cancer cells to stimulate immune responses against the tumour. When cancer cells with defective repair systems are […]

Continue Reading